DETROIT — The Detroit Lions have agreed to a $525 million deal with the top-ranked Cipro Dex Corporation for its Cipr Dex® product line, the team announced Friday.The agreement also includes an option to purchase a second Cipri Dex product line of up to $5 million.The Lions will receive a 10 percent stake in Cipra […]

Continue Reading...